Mature results from a randomized Phase II trial of cisplatin plus 5-fluorouracil and radiotherapy with or without tirapazamine in patients with resectable Stage IV head and neck squamous cell carcinomas
- 1 May 2006
- Vol. 106 (9), 1940-1949
- https://doi.org/10.1002/cncr.21785
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Tirapazamine, Cisplatin, and Radiation Versus Fluorouracil, Cisplatin, and Radiation in Patients With Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02)Journal of Clinical Oncology, 2005
- Phase I Trial of Concurrent Tirapazamine, Cisplatin, and Radiotherapy in Patients With Advanced Head and Neck CancerJournal of Clinical Oncology, 2001
- Repeatability and prognostic impact of the pretreatment pO2 histography in patients with advanced head and neck cancerRadiotherapy and Oncology, 2000
- A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapyRadiotherapy and Oncology, 2000
- Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcomeRadiotherapy and Oncology, 1999
- Concurrent tirapazamine and radiotherapy for advanced head and neck carcinomas: a phase II studyInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Modification of the antitumor activity of chemotherapeutic drugs by the hypoxic cytotoxic agent tirapazamineCancer Chemotherapy and Pharmacology, 1997
- Oxygen Tension Measurements of Head and Neck CancersJAMA Otolaryngology–Head & Neck Surgery, 1994
- SR 4233 (Tirapazamine): a new anticancer drug exploiting hypoxia in solid tumoursBritish Journal of Cancer, 1993
- Hypoxic fractions of solid tumors: Experimental techniques, methods of analysis, and a survey of existing dataInternational Journal of Radiation Oncology*Biology*Physics, 1984